|
For our research on
this condition, we consulted the following journals:
American Journal of
Opthamology
Annals of Epidemiology
J. of Amer. College of Nutrition
Archives of Biochemistry & Biophysics
J. of French Opthamol.
British J. of Opthamology
J. of Indian Med. Assn.
Expert Opinion—Pharmacology
J. of Occular Pharmacology
FASEB J.
J. of Opthamolic Nursing Tech.
Gene Therapy
Oncogene
Indian J. of Opthamology
Opthamology
J. of Indian Med. Assn.
Optometry
Seminars in Opthamology
It appears that macular
degeneration, which can lead to blindness, is caused by "neovascularization,"
the unwanted development of new blood supply to the eye, also called
angiogenesis.
It may be preventable.
The coloring matter in plants, called carotenoids appear to be helpful.
Good sources are blackberries, blueberries, bilberry, dark grapes and
wild cherry. Whether they can help in treatment has not been proven.
Another theoretical
approach, possibly in addition to the above, would be the use of
Ginkgo--standardized at a 50-1 preparation, meaning 50 pounds of Ginkgo
leaf yielding 1 pound of extract. Weaker than that may not be helpful.
Also, clove oil (a few
drops in tea,) may help.
In the drug approach,
physician-scientists at Weill Medical College of Cornell U., New York,
have shown that animals given angiostatin have significantly improved
sight. This use is currently undergoing clinical trials.
This is good news, as
angiostatin is a drug with few side effects.
Also, genistein, found
in soy beans, has the same action, that of inhibiting the signaling
factor that initiates the blood supply creating action.
This factor is called VEGF*.
Lutein, another
carotenoid, found in spinach, was also reported to be protective. On the
other hand, zinc which has been used, was not found to be effective.
One approach to
treatment is the inhibiting of PAI-1**, when adverse effects of the use
of another method, laser photocoagulation appear.
There does not seem to
be a safe, proven medically based treatment as yet, although there are
advocates for the above-mentioned approaches and that of the use of the
drug verteporfin (generic name,) for some types of the disease,
especially in Europe. Additionally there has been a test in the U.S.
which appeared to be successful.
DETAILS: Tobacco smoke
is a contributing cause of this age-related disease, as is inadequate
intake of the anti-oxidant carotenoids.
*Vascular Endothelial
Growth Factor
**Plasminogen Activator Inhibitor 1.
back
to Women's Health index

TOP OF PAGE
SEARCH BY SUBJECT -
TABLE OF CONTENTS
THIS MONTH'S HEALTH
BULLETIN NEWS

If you
find Health Bulletin
interesting,
please click here to "Tell a Friend"


click here |